The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCL.L Regulatory News (MCL)

  • There is currently no data for MCL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman Res.: Profitable and sustainable franchise

20 Oct 2017 07:15

RNS Number : 1370U
Morses Club PLC
20 October 2017
 

Hardman Res.: Profitable and sustainable franchise

Building a profitable and sustainable franchise - The key message from the H1FY18 results is that it confirms MCL's fundamental approach to business. It is building a long-term franchise, carefully assessing risk and returns and prioritising resource to the most value-added area. In this period, the unique opportunity in home collect credit (HCC) was clearly the priority. Book acquisitions and some other new product areas were temporarily less of a management focus although we expect growth from them in due course. The modest online lending pilot is still in pilot stage and will be rolled out carefully. FY19 estimates are broadly unchanged (EPS up 24% on FY17).

Please click here for the full report:

http://hardmanandco.com/docs/default-source/company-docs/morses-club-plc-documents/20.10.17-building-a-profitable-and-sustainable-franchise.pdf

To contact us:

Hardman & Co

35 New Broad Street

London

EC2M 1NH

Contacts:

Mark Thomas

mt@hardmanandco.com

 

Telephone: +44 20 7194 7622

Follow us on Twitter @HardmanandCo

www.hardmanandco.com 

About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADKLFFDBFLFBK
Date   Source Headline
9th Sep 20217:00 amRNSTrading Update
8th Sep 20216:07 pmRNSResult of Court Meeting and General Meeting
3rd Sep 202110:16 amRNSDirectors/PDMRs Dealings
23rd Aug 20211:00 pmRNSCorrection to Notice of General Meeting
16th Aug 20217:00 amRNSIssue of Equity
13th Aug 20217:01 amRNSTrading Update
13th Aug 20217:00 amRNSProposals for new holding company
22nd Jun 202111:30 amRNSResult of AGM
22nd Jun 20217:00 amRNSTrading Update
16th Jun 20215:05 pmRNSAIM Rule 17 Disclosure
14th May 20219:06 amRNSDirector/PDMR Shareholding
13th May 20212:18 pmRNSAnnual Report and Notice of General Meeting
13th May 20217:00 amRNSPreliminary results
29th Apr 20217:00 amRNSBoard Appointments
28th Apr 20217:00 amRNSChange of Registered Office
11th Mar 20217:00 amRNSDirectorate Change
4th Mar 20217:00 amRNSTrading Update
2nd Mar 20219:00 amRNSMorses Club CEO appointed to Board of CCTA
26th Feb 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSDirectorate Change
27th Jan 20218:44 amRNSReplacement: Director/PDMR Dealings
25th Jan 202111:38 amRNSDirectors/PDMRs Dealings
13th Jan 20217:00 amRNSIssue of Equity
7th Jan 202110:30 amRNSResult of General Meeting
24th Dec 20209:56 amRNSDirector/PDMR Shareholding
22nd Dec 20209:51 amRNSDirector/PDMR Shareholding
18th Dec 20204:35 pmRNSDirector/PDMR Shareholding
18th Dec 20207:00 amRNSInterim Results
17th Dec 20203:45 pmRNSNotice of Interim Results
10th Dec 202011:05 amRNSRegulatory Approval Received for New CFO
27th Nov 20207:01 amRNSAnnual Report and Accounts
27th Nov 20207:00 amRNSPreliminary results
26th Nov 20207:00 amRNSPublication of FY20 Results
23rd Nov 202010:41 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAppointment of Chief Financial Officer
22nd Sep 202010:00 amRNSResult of AGM
17th Sep 20207:00 amRNSTrading Update
15th Sep 20204:35 pmRNSPrice Monitoring Extension
27th Aug 20207:00 amRNSReporting Deadline
25th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20207:00 amRNSNotice of Annual General Meeting
18th Aug 20207:00 amRNSNew Strategic Contract for U Account
14th Aug 202011:40 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSTrading and 2020 Results Update
4th Aug 20207:00 amRNSChange of Adviser
29th Jul 20201:41 pmRNSAIM Rule 17 notification
16th Jul 20207:00 amRNSTrading Update
13th Jul 20207:00 amRNSRe-commencement of Lending to New HCC Customers
30th Jun 20201:56 pmRNSResumption of U Account operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.